Interferon-alpha deficiency in covid-19 patients: new therapeutic perspectives

Publication by CIRI in The Journal of Allergy and Clinical Immunology, on April 24, 2020. A collaborative study involving clinical teams from Hospices Civils de Lyon, several research teams from the International Research Center for Infectious Diseases - (CIRI - Inserm/CNRS/ENS de Lyon/UCBL) and the HCL-bioMérieux joint research unit has just been accepted for publication by The Journal of Allergy and Clinical Immunology , an international medical journal. It focuses on very specific proteins, Type 1 interferons, and directs us towards new therapeutic avenues for COVID-19 patients. Source: Type I IFN immunoprofiling in COVID-19 patients . Sophie Trouillet-Assant, Sebastien Viel, PharmD, Alexandre Gaymard, Sylvie Pons, Jean-Christophe Richard, Magali Perret, Marine Villard, Karen Brengel-Pesce, Bruno Lina, Mehdi Mezidi, Laurent Bitker, Alexandre Belot, COVID HCL Study group. Journal of Allergy and Clinical Immunology, April 29, 2020
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience